The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PIONEER: A multicenter, open-label, randomized phase II trial of second-line apatinib plus chemotherapy versus chemotherapy alone in gastric and gastroesophageal junction adenocarcinoma (GA/GEA) refractory to or intolerant of prior anti-PD-1 therapy.
 
Dandan Yu
No Relationships to Disclose
 
Hongli Liu
No Relationships to Disclose
 
Jianli Hu
No Relationships to Disclose
 
Hong Ma
No Relationships to Disclose
 
Jun Xue
No Relationships to Disclose
 
Junli Liu
No Relationships to Disclose
 
Jing Wang
No Relationships to Disclose
 
Zhenyu Lin
No Relationships to Disclose
 
Min Jin
No Relationships to Disclose
 
Shengli Yang
No Relationships to Disclose
 
Lei Zhao
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose